http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011502535-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2008-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011502535-A |
| titleOfInvention | Tumor necrosis factor superfamily mRNA expression through Fc receptors in peripheral blood leukocytes |
| abstract | Disclosed are methods for predicting patient responsiveness to treatment of rheumatoid arthritis involving changes in expression of the tumor necrosis factor superfamily (“TNFSF”)-2, TNFSF-8, or TNFSF-15. Also disclosed are methods for monitoring the effectiveness of such treatments. Further disclosed are methods of screening for compounds for use in the treatment of rheumatoid arthritis. Also disclosed is a method for monitoring disease status over time in patients with rheumatoid arthritis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014057582-A |
| priorityDate | 2007-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 171.